Prediction of the targets of the main components in blood after oral administration of Xanthii Fructus: a network pharmacology study
- PMID: 35539827
- PMCID: PMC9078587
- DOI: 10.1039/c8ra00186c
Prediction of the targets of the main components in blood after oral administration of Xanthii Fructus: a network pharmacology study
Abstract
Xanthii Fructus (XF), a famous traditional Chinese medicine (TCM), has been widely used in the treatment of rhinitis and other diseases. However, the targets of the main XF components found in the blood after oral administration of XF extract are still unclear. In the current study, a feasible systems pharmacology method was developed to predict these targets. In accordance with our previous research, XF components were selected including cleomiscosin A, myristic acid, succinic acid, xanthosine, sitostenone, emodin, apigenin, and chrysophanol. Three components, namely emodin, apigenin, and chrysophanol, failed to be detected with target proteins, thus the other five components, namely cleomiscosin A, myristic acid, succinic acid, xanthosine and sitostenone, were eventually chosen for further systematic analysis. Ninety-nine target proteins and fifty-two pathways were found after a series of analyses. The frequency of some target proteins was much higher than that of others; high frequencies were obtained for P15086, P07360, P07195, MAOM_HUMAN (P23368), P35558, P35520, ACE_HUMAN (P12821), C1S_HUMAN (P09871), PH4H_HUMAN (P00439), FPPS_HUMAN (P14324), P50613, P12724, IMPA1_HUMAN (P29218), HXK1_HUMAN (P19367), P14061, and MCR_HUMAN (P08235). The frequency of eight pathways was also high, including Generic Transcription Pathway, RNA Polymerase II Transcription, Metabolism, Metabolism of steroids, Gene expression (Transcription), Cellular responses to stress, Platelet activation, signaling and aggregation, Signaling by Receptor Tyrosine Kinases, and Cellular Senescence. This study identified a common pathway - the Metabolism pathway - for all five XF components. We successfully developed a network pharmacology method to predict the potential targets of the main XF components absorbed in serum after oral administration of XF extract.
This journal is © The Royal Society of Chemistry.
Conflict of interest statement
The authors have declared no conflicts of interest.
Figures
Similar articles
-
Ultra-high-performance liquid chromatography with tandem mass spectrometry method for determination of four compounds in rat plasma after oral administration of Xanthii fructus and stir-fried Xanthii fructus extracts.Biomed Chromatogr. 2019 Apr;33(4):e4464. doi: 10.1002/bmc.4464. Epub 2019 Jan 21. Biomed Chromatogr. 2019. PMID: 30536751
-
Prediction of the Active Components and Possible Targets of Xanthii Fructus Based on Network Pharmacology for Use in Chronic Rhinosinusitis.Evid Based Complement Alternat Med. 2022 Feb 3;2022:4473231. doi: 10.1155/2022/4473231. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35287308 Free PMC article.
-
Xanthii fructus inhibits inflammatory responses in LPS-stimulated RAW 264.7 macrophages through suppressing NF-κB and JNK/p38 MAPK.J Ethnopharmacol. 2015 Dec 24;176:394-401. doi: 10.1016/j.jep.2015.11.020. Epub 2015 Nov 10. J Ethnopharmacol. 2015. PMID: 26560439
-
Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.Comput Biol Chem. 2021 Feb;90:107358. doi: 10.1016/j.compbiolchem.2020.107358. Epub 2020 Aug 8. Comput Biol Chem. 2021. PMID: 33243703 Review.
-
[Comprehensive evaluation and risk control measures of Xanthii Fructus].Zhongguo Zhong Yao Za Zhi. 2017 Nov;42(21):4079-4085. doi: 10.19540/j.cnki.cjcmm.20170919.009. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 29271143 Chinese.
Cited by
-
Network Pharmacology-Based Approach to Revealing Biological Mechanisms of Qingkailing Injection against IschemicStroke: Focusing on Blood-Brain Barrier.Evid Based Complement Alternat Med. 2020 Aug 27;2020:2914579. doi: 10.1155/2020/2914579. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32908557 Free PMC article.
References
-
- Wang J. Li X. J. Drug targets discovery based on dynamic signal transduction networks. Acta Pharm. Sin. 2010;45(1):1–8. - PubMed
-
- Wang N. Zheng Y. Gu J. Cai Y. Wang S. Zhang F. Chen J. Situ H. Lin Y. Wang Z. Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis. Sci. Rep. 2017;7(1):14513–14528. doi: 10.1038/s41598-017-15030-3. - DOI - PMC - PubMed
-
- Lyu M. Yan C. L. Liu H. X. Wang T. Y. Shi X. H. Liu J. P. Orgah J. Fan G. W. Han J. H. Wang X. Y. Zhu Y. Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection. Sci. Rep. 2017;7(1):15427–15445. doi: 10.1038/s41598-017-14692-3. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous